Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 130 | 111 | 81 | 36 | 629 |
| Cost of Goods | N/A | N/A | N/A | 0 | 262 |
| Gross Profit | 130 | 111 | 81 | 36 | 367 |
| Operating Expenses | 8,562 | 7,759 | 8,455 | 7,821 | 7,799 |
| Operating Income | -8,432 | -7,648 | -8,374 | -7,785 | -7,170 |
| Interest Expense | 1,468 | 932 | 468 | 222 | 264 |
| Other Income | -4,748 | -3,938 | -602 | -630 | -490 |
| Pre-tax Income | -14,648 | -12,518 | -9,445 | -8,636 | -7,924 |
| Net Income Continuous | -14,648 | -12,518 | -9,445 | -8,636 | -7,924 |
| Net Income | $-14,648 | $-12,518 | $-9,445 | $-8,636 | $-7,924 |
| EPS Basic Total Ops | -2,200.00 | -5,466.67 | -5,800.00 | -7,000.00 | -10,666.67 |
| EPS Basic Continuous Ops | -2,191.78 | -5,468.68 | -5,806.38 | -7,011.42 | -10,680.46 |
| EPS Diluted Total Ops | -2,200.00 | -5,466.67 | -5,800.00 | -7,000.00 | -10,666.67 |
| EPS Diluted Continuous Ops | -2,191.78 | -5,468.68 | -5,806.38 | -7,011.42 | -10,680.46 |
| EBITDA(a) | $-4,544 | $-5,118 | $-7,496 | $-6,984 | $-6,617 |